Among major unmet needs in allogeneic stem cell transplantation (HSCT), the identification of a suitable donor, the control of infection complications (where cytomegalovirus [CMV] is paradigmatic), and the reduction of both disease relapse and graft-versus-host disease (GVHD) represent 4 key challenges.
No takes yet. Share an insight, caveat, or question.
Lorentino et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: